
March 7, 2002
Although it has been seven months since Bayer AG officially halted production of Baycol due to the alarming number of serious side effects associated with the drug, lawsuits are still being filed in court. Four former Baycol users who claim they suffered serious health problems after using the drug filed suit in state and Federal court in Oregon this week.
The complaints allege that the German pharmaceutical company pushed the drug onto the U.S. market without adequate warning to doctors about negative side effects. Baycol is a member of the statin family of cholesterol-lowering drugs. Bayer pulled the drug from the market because of Baycol's association with myositis and rhabdomyolysis, conditions characterized by severe muscle weakening, soreness, and kidney damage. The four plaintiffs seek a total of $15 million in compensation.
-- Article Courtesy of InjuryBoard.com
.
Contents & Site Design © Injury Issues.com